Arcturus Therapeutics Holdings (ARCT) Total Debt (2018 - 2025)

Arcturus Therapeutics Holdings (ARCT) has 7 years of Total Debt data on file, last reported at $15.0 million in Q1 2025.

• Quarterly Total Debt changed N/A year-over-year to $15.0 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $15.0 million (changed N/A YoY) and the FY2022 annual result came in at $111.1 million, up 75.98% from the prior year.
• Total Debt fell to $15.0 million in Q1 2025, from $20.0 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $111.1 million in Q4 2022 to a low of $15.0 million in Q1 2025.
• A 4-year average of $57.9 million and a median of $61.3 million in 2021 frame the typical range for Total Debt.
• Annual changes were most pronounced in 2021 — Total Debt soared 318.07% — and 2023, when it sank 66.52%.
• Tracing ARCT's Total Debt over 4 years: stood at $63.1 million in 2021, then surged by 75.98% to $111.1 million in 2022, then plunged by 81.99% to $20.0 million in 2023, then retreated by 25.0% to $15.0 million in 2025.
• The last three Total Debt figures came in at $15.0 million (Q1 2025), $20.0 million (Q3 2023), and $111.1 million (Q4 2022), per Business Quant data.